biome glp 1 Trim GLP-1 (Label) | Dietary Supplement Label Database (DSLD) Prebiotics Explained: How They Support
Description
Lancet 372(9645):12401250
Eleven states covered all three GLP-1s approved for obesity treatment
A study published in JAMA Ophthalmology found that patients prescribed semaglutide experienced NAION at a rate over seven times higher than those on other medications
Notably, no significant increase was observed for older GLP-1 medications like liraglutide, dulaglutide, exenatide, or lixisenatide
